Financial Daily from THE HINDU group of publications
Sunday, Mar 31, 2002

Investment World
Features
Stocks
Port Info
Archives

Group Sites

Investment World - Industry Analysis
Info-Tech - Software


Wait and watch

Krishnan Thiagarajan

THE price earnings multiple of most frontline software companies have remained locked in a relatively narrow band over the past few months (occasional swings notwithstanding). This was in stark contrast to the sharp appreciation in the valuation of medium-sized companies. The relatively better and reliable flow of information have reduced the volatility in the frontline stocks vis-à-vis the speculative burst of activity in medium-sized companies. But do the fundamentals justify an entry into select frontline stocks at this point in time? These stocks can be avoided for now, as the risk-return paradigm has changed completely and the full impact of certain developments affecting the sector will become evident only over the coming months. The following developments will have a bearing on valuation:

  • First, before buying afresh or raising exposure in frontline companies, it may be better to wait for Infosys Technologies to outline its management guidance for 2002-03 on April 10. That will probably serve as a yardstick to judge other companies. The only inference we can draw at this stage is that if the revenue growth is pegged at 30 per cent or above, it may be a positive primarily because anything below that would take a toll on the future per share earnings growth.

  • Over the next nine months to a year, the immense potential for large-scale offshore outsourcing from Fortune 500/Global 1000 may not be fully realised. As indicated elsewhere, that is mainly because revenue buoyancy may lag the recovery of the US economy, decision cycles are likely to remain long, billing rates may remain under pressure till the overcapacity in the industry gets absorbed, and the technology over-investment spiral abates.

  • As the frontline players attempt to move up the software value chain, the business model is undergoing a significant change. It may take up to two years for the success of these plans to get reflected in the financial performance.

  • As the US stock market stabilises, it is likely that frontline companies will contemplate aggressive acquisition plans. But given the near-term uncertainties associated with these acquisitions, these stocks may be subject to extreme volatility; hardly desirable for small investors.

  • If Tata Consultancy Services makes its IPO this year, it could decisively swing the valuation of the sector and affect the valuation of several frontline companies such as Infosys, Wipro, Satyam and HCL Technologies.

    Investment recommendations: For investors with a medium-term perspective, Infosys Technologies is recommended at Rs 3,200-3,300. However, it is best for investors (with varying risk profiles) to wait for Infosys to announce its revenue forecast for 2002-03. Even after providing for a healthy PEM differential over Infosys, Wipro may be appropriate only at Rs 1,350-1,450. Satyam Computers looks fairly attractive at the current level of Rs 267, but as it has not fully firmed up its plans to move up the software value chain, investors may be better off waiting-and-watching. It may be prudent to avoid investing in HCL Technologies and Hughes Software for now.

    Send this article to Friends by E-Mail

  • Stories in this Section
    Frontline software companies -- Trying to move up value chain


    Big fight for the long haul
    China: The hidden dragon
    Dominant trends
    Wait and watch
    Why inflation numbers are important
    Children's insurance policies: Growing up, assured
    IDBI Principal Growth Fund: Hold
    Equity funds in Q1: One in four beat broad indices
    Birla IT Fund: Pare exposures
    Gilt in debt funds
    Chola Liquid Fund (Cumulative Option): Invest
    Balanced funds partying too
    Benchmarking performance
    SEBI mandates disclosure of index-benchmarked performance
    Templeton India Growth Fund: Invest
    Balrampur Chini: Book profits, now
    Gujarat Ambuja Cements: Hold
    Kodak India: Buy
    Aventis Pharma: Buy
    Clariant India: Hold
    Unichem Laboratories: Buy
    Lacklustre trading
    Nasdaq: Uptrend to continue
    Long-term debt options riskier now
    Steady week for index put, call
    Volumes decline on bourses
    April contracts active
    Futures guide
    Options - Help guide
    Mahindra & Mahindra Financial Services: For the short run
    Gazing the market crystal ball -- Mr P. V. Ranganathan, technical analyst and director, kry
    Significant action in Hindustan Zinc
    Trim exposures in ITC, HLL
    Weak trend in Punjab Tractors
    Depreciation claim and asset costs
    Mindteck (India): Invest
    Creeping acquisition: SEBI's time-frame pleases promoters
    Getting policies right the first time
    Range-bound movements likely


    The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
    Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

    Copyright © 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line